Global Blood Therapeutics, Inc.

CIK 1629137 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Global Blood Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Feb 14, 2023SC 13G/A0001172661-23-000829
Feb 9, 2023SC 13G/A0000315066-23-001628
Oct 17, 202215-12G0001193125-22-263393
Oct 6, 202240000899243-22-033163
Oct 6, 202240000899243-22-033149
Oct 6, 202240000899243-22-033160
Oct 6, 202240000899243-22-033145
Oct 6, 202240000899243-22-033159
Oct 6, 202240000899243-22-033156
Oct 6, 202240000899243-22-033150
Oct 6, 202240000899243-22-033162
Oct 6, 202240000899243-22-033151
Oct 6, 202240000899243-22-033147
Oct 6, 202240000899243-22-033157
Oct 6, 202240000899243-22-033146
Oct 6, 202240000899243-22-033161
Oct 6, 202240000899243-22-033144
Oct 6, 202240000899243-22-033158
Oct 6, 202240000899243-22-033148
Oct 5, 2022S-8 POS0001193125-22-258256
Oct 5, 2022S-8 POS0001193125-22-258249
Oct 5, 2022S-8 POS0001193125-22-258246
Oct 5, 2022S-8 POS0001193125-22-258252
Oct 5, 2022S-8 POS0001193125-22-258254
Oct 5, 2022S-8 POS0001193125-22-258244